PRESS DIGEST- Financial Times - Oct 22
The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
Regulatory News - Americas Headlines
Nutrien vows to 'protect interests' over threat to SQM sale -paper
Canada's Nutrien, whose attempt to sell its stake in Chilean lithium miner SQM to China's Tianqi has been stalled by a row about competitive risks, vowed to "protect its interests" in an interview with a Chilean newspaper published on Sunday.
AstraZeneca's Lynparza shown to put brakes on ovarian cancer
An AstraZeneca drug that blocks a cancer cell's ability to repair its genetic code greatly reduced the risk of ovarian cancer worsening in a phase III trial, underpinning its lead against two U.S. rivals in the same class.
Roche takes on Loxo, Bayer in gene-defined cancer class
Roche's entrectinib cancer pill was shown to shrink tumours in 57 percent of patients within a group that can only be identified via genetic profiling, as the Swiss drugmaker challenges an alliance of Bayer and Loxo Oncology in a new targeted treatment area.
Germany's Scholz wants global tax floor to stop evasion
Germany's Finance Minister Olaf Scholz has proposed a global minimum rate of corporation tax coupled with tougher measures to prevent tax evaders from stashing their profits in tax havens, newspaper Welt am Sonntag reported.
REFILE-UPDATE 1-Google to charge Android partners up to $40 per device for apps -source
Alphabet Inc's Google will charge hardware firms up to $40 per device to use its apps under a new licensing system to replace one that the European Union this year deemed anti-competitive, a person familiar with the matter said on Friday.
CORRECTED-Sanofi drug Dupixent wins U.S. FDA approval to treat asthma
France's Sanofi SA said on Friday eczema drug Dupixent was approved by the U.S. Food and Drug Administration as an additional maintenance therapy in patients with two types of asthma.
Google to charge Android partners up to $40 per device for apps - source
Alphabet Inc's Google will charge hardware firms up to $40 per device to use its apps under a new licensing system to replace one that the European Union this year deemed anti-competitive, a person familiar with the matter said on Friday.
U.S. SEC investigates Honeywell for asbetos-related accounting
Honeywell International Inc said on Friday the U.S. Securities and Exchange Commission had opened an investigation into its accounting for asbestos-related liabilities.
EU mergers and takeovers (Oct 19)
The following are mergers under review by the European Commission and a brief guide to the EU merger process:
Business Video
Big techs Amazon, Alphabet and Microsoft compete for attention with the ECB when they post their quarterly results later this week. And as David Pollard reports, tensions over Saudi's alleged involvement in the death of a journalist may surface ahead of the kingdom's investor conference - from which many high profile guests have pledged to stay away.
Top News
Saudi Arabia calls Khashoggi killing 'grave mistake,' says prince not aware
Saudi Arabia on Sunday called the killing of journalist Jamal Khashoggi at its Istanbul consulate a "huge and grave mistake," but sought to shield its powerful crown prince from the widening crisis, saying Mohammed bin Salman had not been aware.